Journal of Hematology & Oncology

official impact factor 2.93
Search for
Advanced search
Journal of Hematology & Oncology
Tools
Share this article
Open Access

BCR-ABL1-independent PI3Kinase activation causing imatinib-resistance

Hilmar Quentmeier*, Sonja Eberth, Julia Romani, Margarete Zaborski and Hans G Drexler

  • * Corresponding author: Hilmar Quentmeier hqu@dsmz.de

Journal of Hematology & Oncology 2011, 4:6 doi:10.1186/1756-8722-4-6

Accesses  

  • Last 30 days: 201 accesses
  • Last 365 days: 2269 accesses
  • All time: 3614 accesses

Cited by

BioMed Central: 1 citation

Letter to the Editor   Open Access Highly Accessed

Dasatinib preferentially induces apoptosis by inhibiting Lyn kinase in nilotinib-resistant chronic myeloid leukemia cell line

Seiichi Okabe, Tetsuzo Tauchi, Yuko Tanaka, Kazuma Ohyashiki Journal of Hematology & Oncology 2011, 4:32 (2 August 2011)

Abstract | Full text | PDF | PubMed

Google Scholar: View citations

ISI Web of Science: View citations

PubMed Central: View citations